|
⚲
|
| Keyboard |
| Yeh Yung-Ping
✚
|
|
|---|---|
| CIK # | 0001850320 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001850320] | |
| 4 | [0001850320] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Yeh Yung-Ping | |
| Cancer Genetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2022-03-30 | Grant | 43,478 | ||
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-11-22 | Buy | 500 | $2.05 | 1,025 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-08-25 | Buy | 1,000 | $2.64 | 2,640 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-05-20 | Buy | 1,000 | $3.29 | 3,290 |
|
Cancer Genetics Inc VYNT
Common Stock, $0.0001 par value
|
2021-03-30 | Other | 1,328,602 | ||
|
Cancer Genetics Inc VYNT
Stock option (right to buy) · derivative
|
2021-03-30 | Grant | 150,000 | $0.00 | |
|
Cancer Genetics Inc VYNT
Stock option (right to buy) · derivative
|
2021-03-30 | Other | 51,825 | $0.00 |